News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vitae Pharmaceuticals, Inc. CEO Jeffrey Hatfield Joins the Biotechnology Industry Organization (BIO)'s Board of Directors


10/5/2011 10:06:56 AM

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals today announced Jeffrey Hatfield, the Company’s President and Chief Executive Officer, was elected to the Board of Directors of the Biotechnology Industry Organization (BIO), effective immediately. During his 2011-2012 tenure on the BIO Board, Mr. Hatfield will initially serve on two Governing Committees: the Intellectual Property committee and the Emerging Company Section Capital Formation committee.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES